Iron deficiency anemia (IDA) is a common health concern worldwide, often not receiving adequate clinical attention despite its significant impact on health [1, 2]. It is a condition where the body lacks sufficient iron to produce enough healthy red blood cells, leading to various symptoms and potentially serious health consequences [1, 4].
What is Iron Deficiency Anemia?
Anemia is a well-known consequence of iron deficiency (ID), but it's crucial to understand that iron deficiency can exist and cause symptoms long before anemia develops [4]. Iron deficiency means the body's iron stores are low, which can lead to symptoms like lethargy, altered mood, and poor concentration, significantly reducing an individual's quality of life [4]. When iron deficiency progresses to anemia, it means there aren't enough red blood cells to carry oxygen effectively throughout the body [1, 4].
This condition is highly prevalent across all populations, particularly among hospitalized patients, children, and young women [1, 2]. It is associated with worse clinical outcomes, including longer hospital stays, diminished quality of life, and an increased risk of illness and death [1].
Common Causes of Iron Deficiency
The reasons for iron deficiency vary depending on geographical and socioeconomic factors:
- In developing countries, poor iron intake and parasitic infections are frequent causes [2].
- In high-income countries, common causes include vegetarian diets, poor iron absorption, and chronic blood loss [2].
Conditions that impair iron absorption, such as autoimmune gastritis, celiac disease, or gastric surgery, can also lead to iron deficiency anemia [8]. Additionally, certain medical treatments, like erythropoiesis-stimulating agents, can result in 'functional' iron deficiency, where the body has iron stores but cannot effectively use them for red blood cell production [2].
Recognizing Symptoms and Getting Diagnosed
Symptoms of iron deficiency can include fatigue, shortness of breath, lethargy, altered mood, and poor concentration [4, 7]. In children, especially neonates born with iron deficiency, there can be a significant increase in cognitive and behavioral abnormalities that may persist even after iron levels are restored [3, 4].
Diagnosing iron deficiency is generally straightforward through blood tests, although it can be more complex when inflammatory disorders are present [2]. Healthcare providers will evaluate iron levels and other blood markers to determine the extent of iron deficiency and whether anemia has developed [1, 2].
Effective Treatment Approaches
Treating iron deficiency and IDA typically involves replenishing the body's iron stores. The primary treatment options are oral iron supplements and intravenous (IV) iron administration.
-
Oral Iron: Oral iron salts are often the first-line therapy for absolute iron deficiency, as low levels of a hormone called hepcidin facilitate iron absorption [2, 3]. However, frequent side effects, such as gastrointestinal upset, can limit their effectiveness and patient adherence [2, 3].
-
Intravenous Iron: IV iron is increasingly used, especially when oral iron is not tolerated, ineffective, or when rapid iron repletion is needed [2, 3]. It is also effective in cases of functional iron deficiency or when iron malabsorption is a concern [2, 8]. Modern IV iron formulations, which have carbohydrate cores that bind elemental iron more tightly, allow for complete replacement doses to be administered quickly, often within 15 to 60 minutes, while minimizing the release of free iron [3]. Ferric carboxymaltose (FCM) is one such IV iron preparation that has shown efficacy and good tolerability in patients with iron malabsorption-related IDA [8].
Iron Deficiency in Specific Populations
Certain groups are at higher risk and require particular attention for iron deficiency management:
-
Pregnancy: Iron deficiency is the most common cause of anemia during pregnancy, affecting up to 70% of pregnancies in some regions [3, 4]. Risk factors like having multiple previous pregnancies or heavy uterine bleeding increase its prevalence [3]. Early diagnosis and treatment are crucial because fetal and neonatal iron deficiency is linked to impaired neurocognitive development, with lasting effects even after iron replacement [3, 4].
-
Chronic Kidney Disease (CKD): Anemia is a frequent complication in later stages of CKD, and iron deficiency is a significant contributing factor, alongside erythropoietin deficiency [6, 7]. The management of anemia in CKD is complex and guided by specific clinical practice guidelines [5, 6]. New insights into iron metabolism have clarified the role of chronic inflammation and hepcidin in impairing iron utilization in CKD patients [7].
The Importance of Timely Management
Despite its high prevalence and significant health implications, anemia, particularly iron deficiency anemia, often goes undetected or inadequately managed [1]. Recognizing the symptoms, understanding the causes, and implementing appropriate diagnostic and treatment strategies are essential for improving patient outcomes and quality of life [1, 4]. Early detection and effective management can help prevent the progression of iron deficiency to severe anemia and mitigate its associated risks [1, 3, 4].
Sources
- 1. Iron deficiency anemia--bridging the knowledge and practice gap. (Transfusion medicine reviews, 2014)
- 2. Iron deficiency: new insights into diagnosis and treatment. (Hematology. American Society of Hematology. Education Program, 2015)
- 3. Iron deficiency in gynecology and obstetrics: clinical implications and management. (Hematology. American Society of Hematology. Education Program, 2017)
- 4. Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement. (Internal medicine journal, 2025)
- 5. Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD). (Kidney international, 2026)
- 6. UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease. (BMC nephrology, 2025)
- 7. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. (American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018)
- 8. Efficacy, Safety, and Hematologic Recovery Following Intravenous Ferric Carboxymaltose in Patients with Iron Malabsorption-Related Iron Deficiency Anemia: A Prospective Clinical Study. (Nutrients, 2026)